EMCURE PHARMACEUTICALS- IPO Analysis - 02 July 2024

EMCURE PHARMACEUTICALS- IPO Analysis

5 Things to know about: 1. IPO is open from 3rd July to 5th July with the Price band of 960-1008 per share. With the Issue size of 1952 crores out of which 800 is for the fresh issue and 1152 will be for Offer for sale and it will be listed on both NSE & BSE. 2. It is the 13rd largest largest Pharmaceutical company in terms of domestic sales volume and also has 13 manufacturing facilities in India. 3. There are 2 main reasons for this Issue, a) Prepayment and scheduled repayment of outstanding borrowings b) For General Corporate Purposes. 4. Company's financials are good and with an average growth rate of last 3 years is 7% and less Profit margin is avg due to high expenses. however, company is profitable with an EPS of 27.54 Rs per share and Return on Net Worth is 16.87%. 5. Company Major competitor's are Dr. Reddy Laboratories, Cipla, Alkem Laboratories, Mankind Pharma, which are well postioned in the market, In terms of both, Market share and Financials.